{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:30:22Z","timestamp":1771680622858,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13104-016-2353-3","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:25:12Z","timestamp":1483489512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review"],"prefix":"10.1186","volume":"10","author":[{"given":"Naomi","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sakanashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,4]]},"reference":[{"key":"2353_CR1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","volume":"51","author":"DM Weinberger","year":"2010","unstructured":"Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, R\u00fcckinger S, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis. 2010;51:692\u20139.","journal-title":"Clin Infect Dis"},{"key":"2353_CR2","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.vaccine.2014.02.096","volume":"32","author":"JD Grabenstein","year":"2014","unstructured":"Grabenstein JD, Musey LK. Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults. Vaccine. 2014;32:2399\u2013405.","journal-title":"Vaccine."},{"key":"2353_CR3","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1128\/IAI.73.8.4653-4667.2005","volume":"73","author":"S Hammerschmidt","year":"2005","unstructured":"Hammerschmidt S, Wolff S, Hocke A, Rosseau S, M\u00fcller E, Rohde M. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun. 2005;73:4653\u201367.","journal-title":"Infect Immun"},{"key":"2353_CR4","first-page":"561","volume":"59","author":"N Chiba","year":"2011","unstructured":"Chiba N. Current status of invasive pneumococcal diseases and the preventive pneumococcal vaccines in Japan. Jpn J Chemother. 2011;59:561\u201372.","journal-title":"Jpn J Chemother."},{"key":"2353_CR5","first-page":"303","volume":"4","author":"S Kawasaki","year":"2015","unstructured":"Kawasaki S, Aoki N. A case of severe community-acquired pneumonia caused by mucoid type Streptococcus pneumoniae. Ann Jpn Resp Soc. 2015;4:303\u20138.","journal-title":"Ann Jpn Resp Soc"},{"key":"2353_CR6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jiac.2014.03.010","volume":"20","author":"H Okade","year":"2014","unstructured":"Okade H, Funatsu T, Eto M, Furuya Y, Mizunaga S, Nomura N, et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period. J Infect Chemother. 2014;20:423\u20138.","journal-title":"J Infect Chemother."},{"key":"2353_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vaccine.2015.11.015","volume":"34","author":"S Nakano","year":"2016","unstructured":"Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Noguchi T, et al. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012\u20132014. Vaccine. 2016;34:67\u201376.","journal-title":"Vaccine."},{"key":"2353_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122247","author":"K Morimoto","year":"2015","unstructured":"Morimoto K, Suzuki M, Ishifuji T, Yaegashi M, Asoh N, Hamashige N, et al. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS ONE. 2015. doi: 10.1371\/journal.pone.0122247 .","journal-title":"PLoS ONE"},{"key":"2353_CR9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jiac.2015.07.002","volume":"21","author":"K Akata","year":"2015","unstructured":"Akata K, Chang B, Yatera K, Kawanami T, Yamasaki K, Naito K, et al. Distribution and annual changes in Streptococcus pneumoniae serotypes in adult Japanese patients with pneumonia. J Infect Chemother. 2015;21:723\u20138.","journal-title":"J Infect Chemother."},{"key":"2353_CR10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/21645515.2015.1118593","volume":"12","author":"WP Hausdorff","year":"2016","unstructured":"Hausdorff WP, Hanage WP. Interim results of an ecological experiment-conjugate vaccination against the pneumococcus and serotype replacement. Hum Vaccin Immunother. 2016;12:358\u201374.","journal-title":"Hum Vaccin Immunother."},{"key":"2353_CR11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/jgs.12863","volume":"62","author":"T Kuroki","year":"2014","unstructured":"Kuroki T, Ishida M, Suzuki M, Furukawa I, Ohya H, Watanabe Y, et al. Outbreak of Streptococcus pneumoniae serotype 3 pneumonia in extremely elderly people in a nursing home unit in Kanagawa, Japan, 2013. J Am Geriatr Soc. 2014;62:1197\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"2353_CR12","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1080\/21645515.2015.1030550","volume":"11","author":"M Shiramoto","year":"2015","unstructured":"Shiramoto M, Hanada R, Juergens C, Shoji Y, Yoshida M, Ballan B, et al. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults. Hum Vaccin Immunother. 2015;11:2198\u2013206.","journal-title":"Hum Vaccin Immunother."},{"key":"2353_CR13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","volume":"14","author":"NJ Andrews","year":"2014","unstructured":"Andrews NJ, Waight PA, Burbidge P, Pearce E, Roalfe L, Zancolli M, et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014;14:839\u201346.","journal-title":"Lancet Infect Dis"},{"key":"2353_CR14","first-page":"822","volume":"63","author":"S Tomczyk","year":"2014","unstructured":"Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565\u00a0years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2353_CR15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.15585\/mmwr.mm6434a4","volume":"64","author":"M Kobayashi","year":"2015","unstructured":"Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2015;64:944\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2353_CR16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/21645515.2015.1075678","volume":"12","author":"H Namkoong","year":"2016","unstructured":"Namkoong H, Ishii M, Funatsu Y, Kimizuka Y, Yagi K, Asami T, et al. Theory and strategy for pneumococcal vaccines in the elderly. Hum Vaccin Immunother. 2016;12:336\u201343.","journal-title":"Hum Vaccin Immunother."},{"key":"2353_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139140","author":"SL Hoshi","year":"2015","unstructured":"Hoshi SL, Kondo M, Okubo I. Economic evaluation of immunisation programme of 23-valent pneumococcal polysaccharide vaccine and the inclusion of 13-valent pneumococcal conjugate vaccine in the list for single-dose subsidy to the elderly in Japan. PLoS ONE. 2015. doi: 10.1371\/journal.pone.0139140 .","journal-title":"PLoS ONE"},{"key":"2353_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jiac.2013.10.010","volume":"20","author":"S Kohno","year":"2014","unstructured":"Kohno S, Tateda K, Kadota J, Fujita J, Niki Y, Watanabe A, et al. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia. J Infect Chemother. 2014;20:199\u2013207.","journal-title":"J Infect Chemother."},{"key":"2353_CR19","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1128\/CVI.00259-14","volume":"21","author":"S Athlin","year":"2014","unstructured":"Athlin S, Kaltoft M, Slotved HC, Herrmann B, Holmberg H, Konradsen HB, et al. Association between serotype-specific antibody response and serotype characteristics in patients with pneumococcal pneumonia, with special reference to degree of encapsulation and invasive potential. Clin Vaccine Immunol. 2014;21:1541\u20139.","journal-title":"Clin Vaccine Immunol"},{"key":"2353_CR20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.45.1.316-318.2001","volume":"45","author":"L Hennezel De","year":"2001","unstructured":"De Hennezel L, Ramisse F, Binder P, Marchal G, Alonso JM. Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model. Antimicrob Agents Chemother. 2001;45:316\u20138.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-016-2353-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:11:59Z","timestamp":1498360319000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-016-2353-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,4]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2353"],"URL":"https:\/\/doi.org\/10.1186\/s13104-016-2353-3","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,4]]},"article-number":"21"}}